This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Aug;49(8):1276-8.

doi: 10.1373/49.8.1276.

Counterpoint: The vision for a new diagnostic paradigm

Emanuel Petricoin 3rd¹, Lance A Liotta

Affiliations

PMID: 12881442
DOI: 10.1373/49.8.1276

Comment

Counterpoint: The vision for a new diagnostic paradigm

Emanuel Petricoin 3rd et al. Clin Chem. 2003 Aug.

. 2003 Aug;49(8):1276-8.

doi: 10.1373/49.8.1276.

Authors

Emanuel Petricoin 3rd¹, Lance A Liotta

Affiliation

¹ NCI-FDA Clinical Proteomics Program, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA.

PMID: 12881442
DOI: 10.1373/49.8.1276

No abstract available

PubMed Disclaimer

Comment in

Clarification in the point/counterpoint discussion related to surface-enhanced laser desorption/ionization time-of-flight mass spectrometric identification of patients with adenocarcinomas of the prostate.
Grizzle WE, Meleth S. Grizzle WE, et al. Clin Chem. 2004 Aug;50(8):1475-6; author reply 1476-7. doi: 10.1373/clinchem.2004.033456. Clin Chem. 2004. PMID: 15277364 No abstract available.

Comment on

Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?
Diamandis EP. Diamandis EP. Clin Chem. 2003 Aug;49(8):1272-5. doi: 10.1373/49.8.1272. Clin Chem. 2003. PMID: 12881441 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems